Literature DB >> 12855368

Ebselen attenuates cochlear damage caused by acoustic trauma.

Akram Pourbakht1, Tatsuya Yamasoba.   

Abstract

Ebselen (2-phenyl-1,2-benzisoselenazol-3(2H)-one), a seleno-organic compound, mimics glutathione peroxidase and reacts with peroxynitrite. It is reported to protect against gentamicin- and cisplatin-induced ototoxicity. We investigated whether it protects the cochlea from acoustic trauma. Male pigmented guinea pigs (250-300 g) with normal auditory brainstem response (ABR) thresholds were exposed for 5 h to 125 dB sound pressure level octave band noise centered at 4 kHz. One hour before and 18 h after exposure, they received orally 0.25 ml chloroform solution containing 0, 10, or 30 mg/kg ebselen (n=6, 5 and 5, respectively). The protective effect of ebselen was evaluated by ABR measurement and quantitative hair cell assessment. Treatment significantly (P<0.01) reduced the extent of permanent threshold shifts and outer hair cell loss. Interestingly, the protective effect of a 30 mg/kg dose was less than that of a 10 mg/kg dose. There were no adverse systemic or auditory function effects in three unexposed control subjects given 30 mg/kg ebselen. These findings indicate that ebselen attenuates noise-induced cochlear damage. The concentration that provides optimal protection against such damage has now to be determined.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12855368     DOI: 10.1016/s0378-5955(03)00178-3

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  28 in total

1.  Current aspects of hearing loss from occupational and leisure noise.

Authors:  S Plontke; H-P Zenner
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2004-12-28

2.  The design and screening of drugs to prevent acquired sensorineural hearing loss.

Authors:  Debashree Mukherjea; Leonard P Rybak; Kelly E Sheehan; Tejbeer Kaur; Vickram Ramkumar; Sarvesh Jajoo; Sandeep Sheth
Journal:  Expert Opin Drug Discov       Date:  2011-03-15       Impact factor: 6.098

Review 3.  Mechanisms of noise-induced hearing loss indicate multiple methods of prevention.

Authors:  Colleen G Le Prell; Daisuke Yamashita; Shujiro B Minami; Tatsuya Yamasoba; Josef M Miller
Journal:  Hear Res       Date:  2006-12-04       Impact factor: 3.208

4.  Free radical scavengers vitamins A, C, and E plus magnesium reduce noise trauma.

Authors:  Colleen G Le Prell; Larry F Hughes; Josef M Miller
Journal:  Free Radic Biol Med       Date:  2007-02-20       Impact factor: 7.376

5.  Dual Release Carriers for Cochlear Delivery.

Authors:  Sahar Rahmani; Astin M Ross; Tae-Hong Park; Hakan Durmaz; Acacia F Dishman; Diane M Prieskorn; Nathan Jones; Richard A Altschuler; Joerg Lahann
Journal:  Adv Healthc Mater       Date:  2015-07-14       Impact factor: 9.933

Review 6.  Otoprotectants: From Research to Clinical Application.

Authors:  Colleen G Le Prell
Journal:  Semin Hear       Date:  2019-04-26

7.  Nutrient plasma levels achieved during treatment that reduces noise-induced hearing loss.

Authors:  Colleen G Le Prell; David F Dolan; David C Bennett; Peter A Boxer
Journal:  Transl Res       Date:  2011-03-09       Impact factor: 7.012

8.  Protective effects of N-acetylcysteine on noise-induced hearing loss in guinea pigs.

Authors:  A R Fetoni; M Ralli; B Sergi; C Parrilla; D Troiani; G Paludetti
Journal:  Acta Otorhinolaryngol Ital       Date:  2009-04       Impact factor: 2.124

9.  The therapeutic effect of thymoquinone on acoustic trauma-induced hearing loss in rats.

Authors:  Mahmut Ogurlu; Ozlem Celebi Erdivanli; Levent Tumkaya; Abdulkadir Ozgur; Zerrin Ozergin Coskun; Suat Terzi; Munir Demirci; Engin Dursun
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-20       Impact factor: 2.503

10.  Gene transfer in human vestibular epithelia and the prospects for inner ear gene therapy.

Authors:  Bradley W Kesser; George T Hashisaki; Jeffrey R Holt
Journal:  Laryngoscope       Date:  2008-05       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.